Galderma’s Nemluvio® (nemolizumab) Demonstrates Long-Term Disease Control in Prurigo Nodularis up to Three Years

2026-02-27 - 06:13

https://mms.businesswire.com/media/20260226796734/en/2732100/19/Galderma_WCM_PN_3-year_data_Multimedia_video.mp4 Read More